Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.
about
Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac diseaseGliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunityDietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseasesDietary gluten and the development of type 1 diabetesAnimal models to study gluten sensitivityThe role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel diseaseType 1 diabetes and gut microbiota: Friend or foe?Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigmsIntestinal barrier function: molecular regulation and disease pathogenesisLeaky gut and autoimmune diseasesIntestinal permeability and its regulation by zonulin: diagnostic and therapeutic implicationsNo evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish populationPossible links between intestinal permeability and food processing: A potential therapeutic niche for glutamineCan exposure to environmental chemicals increase the risk of diabetes type 1 development?Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh.Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism.An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus.Homeostasis of the gut barrier and potential biomarkers.Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat.Zonulin, regulation of tight junctions, and autoimmune diseases.Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trialMolecular signatures differentiate immune states in type 1 diabetic familiesThe present and the future in the diagnosis and management of celiac disease.The osteopontin transgenic mouse is a new model for Sjögren's syndromeAlterations in intestinal permeability.The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders.Modeling of celiac disease immune response and the therapeutic effect of potential drugsKnockout of MIMP protein in lactobacillus plantarum lost its regulation of intestinal permeability on NCM460 epithelial cells through the zonulin pathway.The changing landscape of type 1 diabetes: recent developments and future frontiers.Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics.Type-specific human papillomavirus detection in cervical smears in Romania.Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial.Understanding the role of gut microbiome in metabolic disease risk.
P2860
Q24630692-DBC1E0F6-2B39-4868-893A-7AEF9C245282Q24642680-E3628730-A172-4B5F-A17D-F17CA46D09E2Q24645048-E1B0BAEE-0600-4675-8BA9-205C02648B6BQ26746677-021FA27E-044D-4BA9-9ECE-AE7694A197A6Q26823584-1C442CE6-0E0F-4F16-96DE-0C570873D295Q26859130-2850997F-6E1F-4D03-B4BF-BAD3754BEB89Q27007776-AB23C650-9312-4417-81E7-B456153017F0Q28087084-7E77032C-85CC-4C9F-BCC7-65EEE5745DECQ28249095-A0B38123-E026-41F6-A4A8-0DFE0A646AB7Q28250081-16EE8595-B576-4912-968E-C5CC702D8D34Q28253767-C3DFA4AB-CFFF-4613-95F5-89B16132EAC6Q28273316-6A7D6F6B-48FB-416B-A528-13CBF0667094Q28279518-33F835AC-91CE-46B5-91BB-8E2F0CDEB716Q28287402-67082C9A-6EA8-428E-905D-108B9E49EA5AQ28391541-BF300692-6270-4EFF-AE01-A8F492B8E414Q30422841-6EEA63F6-B2F9-42EE-9054-4BB094986483Q33564179-A1FD2DDB-A08A-4303-9F0C-815135221DC6Q33621407-9AACA65B-767A-41A0-9288-396C6CD74DFBQ33715804-EE2C7E76-3946-4D05-9E60-4784DA061C6CQ34128679-BE7C3579-598D-45BF-9AA0-A47206F1181DQ34200740-11F25F5D-0AE1-4BB8-BFEA-540E7FABED5CQ34281793-47C9147F-532F-44DB-AF97-CCAD419B97D8Q34283907-8F06DDFE-7CA8-4F06-89D8-B403D954E23CQ34283930-4142FFE7-C44F-4397-B7A3-70527BA7AC44Q34300645-CB06C812-379E-43C7-A7F3-6325889D45F4Q34393367-AAA0F2D7-3224-444B-964E-A1DA43E68F97Q34444067-6453EFAA-BE5F-46AF-9D83-0839AD986CDCQ34457345-F98112DC-481D-4984-9288-457946DFB224Q34565345-A04ABD42-EC95-44AC-85DC-CF03535146C7Q34573812-F8D4050D-D85E-4D29-BF4C-6CCCD66CF9F1Q34612493-5ACE13FE-B731-4607-BA0A-034EE8C02365Q34647607-229FA5EE-5607-4E88-B122-EF848A60A438Q34665037-4B7A978E-B596-47EB-B7ED-D631C490834EQ34798574-7007948B-3284-4C8C-9EE1-505251977301Q34875626-11CD303D-3440-4FB3-B58C-5E99AD72DF1DQ34891279-42ED4447-7AED-4D60-A928-BE9E9E095413Q35018923-C8F9F910-0975-4CBB-BFC7-27FFA810BC7BQ35094156-EBD01811-5AD8-4C4A-898E-898C6C9A9CDAQ35218618-A2892851-06E6-45DE-92F2-6467B3A3AB29Q35331225-8DE5712E-700C-4053-9351-2EB45B67DF32
P2860
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Zonulin upregulation is associ ...... diabetes and their relatives.
@ast
Zonulin upregulation is associ ...... diabetes and their relatives.
@en
Zonulin upregulation is associ ...... diabetes and their relatives.
@nl
type
label
Zonulin upregulation is associ ...... diabetes and their relatives.
@ast
Zonulin upregulation is associ ...... diabetes and their relatives.
@en
Zonulin upregulation is associ ...... diabetes and their relatives.
@nl
prefLabel
Zonulin upregulation is associ ...... diabetes and their relatives.
@ast
Zonulin upregulation is associ ...... diabetes and their relatives.
@en
Zonulin upregulation is associ ...... diabetes and their relatives.
@nl
P2093
P356
P1433
P1476
Zonulin upregulation is associ ...... 1 diabetes and their relatives
@en
P2093
Alessio Fasano
Amit Tripathi
Anna Sapone
Dario Iafusco
Deborah Kryszak
Debra Counts
Francesca Laghi
Francesco Prisco
Gabriele Riegler
Laura de Magistris
P304
P356
10.2337/DB05-1593
P407
P577
2006-05-01T00:00:00Z